Eli Lilly and Company (NYSE: LLY) beats the adjusted EPS consensus of approx. $8.89 in Q2 2026 earnings (August 5, 2026, before market open)
Miss
✦ AI-generated prediction
Published on 20. July 2026
·
Predicted for 5. August 2026
·
Based on: Historical Cycle
Eli Lilly reports Q2 2026 on August 5 before market open. EPS consensus is approx. $8.89/share (Meyka/TipRanks); revenue consensus is $20.5B. Structural driver: GLP-1 demand for Mounjaro (diabetes) and Zepbound (obesity) remains relentless; Lilly is market leader in the fast-growing incretin segment. Lilly has consistently beaten estimates in recent quarters. Risk factors: incretin production capacity constraints; potential US drug pricing pressure (IRA implementation). No Polymarket odds found; beat probability structurally high.
Data basis for this prediction
- Meyka.com: LLY Q2 2026 Ergebnis erwartet 5. August vor Marktöffnung (meyka.com, Stand Juli 2026)
- TipRanks/Meyka: EPS-Konsens Q2 2026 ca. 8,89 USD; Umsatz-Konsens 20,50 Mrd. USD
- SEC EDGAR: Eli Lilly Form 8-K FY2026 Q1 – als Referenz für Wachstumstraj. (sec.gov)
- Public.com/LLY: Lilly Earnings History – konsistente Beats (Stand Juli 2026)
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Miss
Eli Lilly meldete am 5. August 2026 vor Marktöffnung ein bereinigtes EPS von 8,38 USD für Q2 2026 – was unterhalb des in der Vorhersage genannten Konsens-Schwellenwerts von ca. 8,89 USD liegt. Die Vorhersage ist daher gemäß ihrem eigenen Maßstab verfehlt. Ursache: Der in der Vorhersage verwendete Konsens-EPS (~8,89 USD, Meyka/TipRanks) war deutlich zu hoch angesetzt – der tatsächliche Analysten-Konsens lag laut Alphastreet/CNBC bei ca. 6,01–6,55 USD je Aktie. Diesen echten Konsens schlug Lilly massiv (~+30–40 %). Umsatz: 22,97 Mrd. USD (+48 % yoy), ebenfalls weit über Konsens (~20,5 Mrd. USD). Quellen: Lilly Investor Relations (investor.lilly.com), PR Newswire (prnewswire.com/news-releases/302843165), Alphastreet (news.alphastreet.com/eli-lilly-and-company-lly-q2-2026-preview-eps-est-6-55-reports-august-5), CNBC (cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026).
📈 Economy
✦ AI
The S&P 500 dropped 4.36% on 5 November 2026 to 7,353.73 — its steepest one-day fall since April 2025 — triggered by an AI-chip selloff that wiped out the post-midterm rally (4 November: +1.72% to 7,698.80). Closing above 7,500 by 13 November requires a +2.0% recovery over 6 trading sessions. Goldman Sachs, Morgan Stanley and JPMorgan maintain year-end targets of 7,400–8,100; S&P 500 EPS growth consensus for 2026 stands at +14% YoY. Downside risks: elevated Treasury yields, persistent AI capex uncertainty. No specific Polymarket/Kalshi market found for this level.
📈 Economy
✦ AI
The BLS releases October 2026 CPI on November 10, 2026 at 8:30 AM ET. Nowflation forecasts 3.82 percent YoY; the Cleveland Fed nowcasting model forecasts 3.74 percent — both clearly above the 3.7 percent threshold. The September 2026 prior reading was exactly 3.7 percent. Rising energy prices (Strait of Hormuz effectively closed since mid-October) and stable core inflation support a further uptick. An existing open platform prediction covers CPI >3.5%; this forecast raises the bar by 20 basis points. A miss would primarily require unexpected weakness in the energy component or food prices.
📈 Economy
✦ AI
Gold (XAU/USD) rose to $4,134.83 on 5 November 2026 — driven by the Democratic midterm sweep (higher fiscal spending expected) and persistent inflation pressure. Kalshi's Dec 31 settlement market shows ~32% probability for a close above $4,400 and ~43% for above $4,300. Reaching the $4,400 year-end target would require a further ~6.4% gain. Supporting factors: fiscal expansion, geopolitical risks, structurally high central bank demand; UBS forecasts $4,800, JPMorgan $6,000 at year-end. Headwind: hawkish Fed stance (Polymarket: 72.5% for a December rate hike to 4.00–4.25%). Prediction anchors on Kalshi's ~32% for >$4,400.